Aims-To obtain quantitative data on the human serological response to Toxoplasma gondii tachyzoite and bradyzoite antigens. Methods-Serum samples from 30 patients who had positive antibody titres against T gondii and from 14 who were seronegative, together with sequential serum samples from four infected individuals, were screened by FAST-ELISA. Results-Serum samples from the 30 seropositive patients showed high IgG and IgM titres against the T gondii tachyzoite antigen but very low responses to cyst antigen. This result was borne out in sequential serum samples from patients with toxoplasmosis. Conclusion-Antibody recognition of the cystic stage of T gondii is low, implying that either this stage is poorly immunogenic or that the antigen load is low. (J Clin Pathol 1995;45:908-9 11) 
IFN-y is thought to inhibit the spread of the parasite in the brain. 5 Immune surveillance of the cystic stage is important for parasite control and prevention of recrudescence. Although serological responses to tachyzoite antigens have been previously studied in patients during infection,69 the humoral immune response to the cystic stage is poorly documented. A number of studies have revealed that the tachyzoite and bradyzoite stage are antigenically distinct,'01' and stage specific antigens exist.'213 Furthermore, western blotting studies with human serum have shown that relatively few cyst antigens are recognised.'41' However, quantitative estimates of cyst antibodies have not been made in humans. We have previously compared the reactivity of murine serum samples to tachyzoite and cyst antigens by the Falcon assay screening test (FAST)/enzyme linked immunosorbent assay (ELISA), 16 and have found that the antibody response is predominantly directed against the tachyzoite. In the present study we have used the same technique to compare human serological responses to tachyzoite and cyst antigen.
The intracellular protozoan parasite Toxoplasma gondii is an important mammalian pathogen. It is geographically widespread, and is thought to infect approximately one third of the world's human population, although the prevalence of the parasite varies from country to country.' The majority of human infections are acquired postnatally by ingestion of tissue cysts in meat or of resistant oocysts from contaminated cat faeces. Infection of the host by Tgondii leads to an acute systemic phase, characterised by the presence of motile proliferative tachyzoites. The acute phase commonly lasts two to three months in human patients and is followed by a chronic phase, in which "dormant" bradyzoites within cysts are found in the skeletal muscles and central nervous tissue.
In immunocompetent hosts parasite proliferation during the acute phase ofthe infection is effectively controlled by a number of host immune response effector systems. The major mediators of resistance to Tgondii are parasite specific, cytotoxic T lymphocytes, which are involved in the destruction of tachyzoites,2 and interferon y (IFN-y), which has a number of immunostimulatory and parasitistatic effects.'
In addition, T gondii specific antibodies have also been implicated in the control of the acute phase of the infection.4 The mechanisms of control of the chronic phase of the infection, however, remain poorly understood, though Methods Tgondii antigen used throughout the study was prepared from RH strain tachyzoites and RRA (Beverley) tissue cysts. Both strains were routinely maintained by serial passage in adult female outbred mice (Tucks No. 1). Tachyzoites were produced by inoculation of mice with 5 x 106 tachyzoites intraperitoneally and collection of parasites three to five days later by peritoneal lavage in phosphate buffered saline (PBS). Tissue cysts were harvested from infected mouse brain approximately eight to 12 weeks after infection with 30 cysts per os and purified through 45% Percoll gradients according to the method of Cornelissen et al. " Soluble antigen extracts were prepared from tachyzoites and cysts for use in the ELISA.
Parasite suspensions were freeze-thawed three times, sonicated on ice five times for 10 seconds at five minute intervals and then left at 40C overnight. The supernatant fluids were collected following centrifugation at 11 000 x g for 60 minutes at 4°C and the protein concentration of the antigen preparation determined using the Bradford protein assay. '8 A panel of human serum samples was supplied by the Toxoplasma Reference Laboratory, Leeds Public Health Laboratory, from patients referred for routine screening. All serum samples had previously been tested using the (fig 3A) , ti by needlestick injury (fig 3B) . In dividuals the time of infection is w mented and it is possible to follow rise in anti-tachyzoite IgM titres, around four weeks after infection and but slightly slower increase in serum serum IgG and IgM responses to cys were once again, less consistent, lI rather later than the anti-tachyzoite r Discussion The present study confirms previous q immunoblotting data in demonstra patient responses to cyst antigens du. Analysis of sequential serum samples showed that the individual serological IgG response to tachyzoites was rapid and strong, and remained at a high level for over 12 months after infection.
In common with other authors,202' we found that the IgM response was more variable. In general, IgM antibody rose to peak levels three to five weeks after infection, then declined to baseline over time. In one transplant recipient, however, there was no IgM response. This is -Cut off T in agreement with earlier observations that not all heart transplant recipients with reactivation -Cut off C of T gondii infection produce specific IgM.22
The serological response to cyst antigen has not been monitored previously but was very low both in random serum samples and in the smaller group of patients involved in the tigens of T 
